bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.02.748999

PharmCast: rapid generation of three-dimensional pharmacophore fingerprints from two-dimensional structure without conformer generation

Abstract

A three-dimensional pharmacophore fingerprint records the binding features a molecule can present. It is a description of a hand in search of a glove. Because it is defined by presented features instead of two-dimensional structure, it can identify pharmacophoric similarity between structurally distinct compounds, which is what scaffold hopping and non-obvious me-too design require. The descriptor has remained a niche tool because its cost is dominated by conformer generation. In the reference pipeline, generating 100 conformers requires 2.82 s of the 2.86 s needed to fingerprint one screening collection compound; the bit calculation requires 0.039 s. We therefore removed the conformational stage. PharmCast is a feedforward neural network that predicts all 10,549 bits of a PharmPrint ensemble fingerprint directly from a SMILES string. On the same machine, PharmCast generated pharmacophore fingerprints for two molecules and compared them in 0.584 ms, whereas the conventional conformer-based pipeline took 5.71 s. PharmCast version 10 was trained on 5,887,229 molecules drawn from a screening collection, activity-backed ChEMBL compounds from 142 to 1000 Da, and peptide loops excised from crystal structures. We evaluated 155,648 purchasable catalog compounds excluded from every training set, 139,700 activity-backed ChEMBL compounds not present in the version 10 training set, and 13,500 peptide loops reserved for testing. Median fingerprint error, Pearson r, and pairwise ranking accuracy were 0.008, 0.980, and 0.936 for screening collection chemistry; 0.016, 0.984, and 0.952 for loop peptides; and 0.027, 0.936, and 0.889 for activity-backed ChEMBL compounds. The reference calculation reproduces itself at an error of 0.006 and r of 0.995. Ensemble pharmacophore fingerprints can therefore be predicted from two-dimensional structure alone at a cost suitable for large-scale collection screening and virtual library exploration. Keywords: pharmacophore, fingerprint, scaffold hopping, surrogate model, virtual screening, applicability domain

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Muskal, S. M., McGregor, M. J.. 2026-09-07. PharmCast: rapid generation of three-dimensional pharmacophore fingerprints from two-dimensional structure without conformer generation. https://doi.org/10.64898/2026.09.02.748999

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A meta-interaction basis for cell-cell communication in tissues

Tissue function depends on signals exchanged between cells and the responses they elicit. Yet whether diverse cell-cell interactions in situ form recurrent sender-receiver programs remains unclear. We present SpiderNet, an interpretable representation-learning framework that discovers such directed programs as a compact basis of cell-cell meta-interactions (MIs) from spatial transcriptomics. SpiderNet jointly learns which sender regulators, ligand-receptor pairs, and receiver targets define each MI and where each program is active across neighboring cell pairs. The resulting representation traces multicellular relays and links communication to cell states, perturbation responses, and phenotypes. SpiderNet recovers ground-truth MIs and their molecular components in simulations and, in real tissues, shows stronger direction-specific agreement with independently curated regulatory programs in senders and receivers than alternative methods. Across more than 5.8 million spatially profiled cells, SpiderNet resolves an SPP1-THBS relay linking monocytes, fibroblasts, and tumor cells within an immune-suppressive ovarian cancer niche, predicts T-cell responses to held-out melanoma-cell perturbations, and identifies a T-cell-associated brain-aging program and age-predictive signals that transfer across regions and platforms. It reveals a recurrent pan-cancer COLLAGEN-linked fibroblast-tumor program whose projected abundance in independent cohorts is associated with poorer survival and non-response to immunotherapy. SpiderNet thus establishes MIs as a reusable organizational layer between molecular interactions and tissue phenotypes, providing a framework to resolve, compare, trace, and perturb multicellular regulation in situ.

bioinformatics↗

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale studies. In addition, existing computational approaches often struggle to effectively integrate heterogeneous biomedical data, capture the complex higher-order topological signatures of biological interactomes, and generalize to unseen entities. Here, we present HANAMI (Heterogeneous grAph coNtrastive leArning for drug-gene-disease Motif predIction), a multi-view deep graph learning framework designed to model complex interactions among drugs, genes, and diseases. HANAMI integrates diverse heterogeneous biomedical knowledge, including chemical structures, genomic sequences, and clinical phenotypes, and leverages relation-aware topology encoding, structure-aware aggregation, and contrastive learning to enable accurate motif prediction with biological context from the network. Systematic evaluation on benchmark datasets shows that HANAMI achieves up to 6% improvements over existing state-of-the-art methods in predicting drug-gene-disease motifs. The framework further demonstrates strong inductive generalization, maintaining an [~]18% performance advantage in zero-shot settings involving previously unseen entities. Beyond predictive performance, HANAMI effectively prioritizes drug-disease relationships investigated in Phase II or III trials while identifying candidate genes that suggest plausible mechanistic links. Together, HANAMI provides a computational framework for interpreting complex biomedical interactions, offering a scalable foundation to accelerate drug repurposing and therapeutic innovation.

bioinformatics↗

PTMExplorer: A Multi-Dimensional Integrative Visualization Platform for Protein Post-Translational Modification Function and Structure

Deciphering the functions of post-translational modifications (PTMs) is a critical bridge connecting large-scale modification proteomics data to mechanistic studies. However, most existing tools for visualizing PTM omics data are limited to site catalogs or single-dimensional feature displays. They lack the capability to simultaneously map user-derived differential modification sites onto multi-dimensional contexts, including protein three-dimensional (3D) structure, evolutionary conservation, functional sites, and disease associations. This limitation makes it difficult for researchers to rapidly assess the biological importance of candidate sites from among a vast number of differentially modified sites. Here, we present PTMExplorer, an interactive platform for the multi-dimensional visualization of protein PTMs. PTMExplorer comprises three core modules: PTM Inspector, built upon ProtVista, provides a multi-track, sequence-feature integrated view incorporating intrinsically disordered region (IDR) prediction (via flDPnn), surface accessibility calculation (via FreeSASA), and UniProt functional annotations; PTM 3D Locator, leveraging the Nightingale/Mol* engine, anchors modification sites onto AlphaFold/Protein Data Bank (PDB) 3D structures through residue mapping via PDBe-SIFTS; and PTM Overview, utilizing the R circlize package, presents a panoramic polar circos plot illustrating modification distribution and inter-group differential regulation. Additionally, three major disease-associated modification databases (PTMD, qPTM, and PhosCancer) are integrated as PTM-Disease Nexus, enabling co-localization comparison between user-defined differential sites and reported disease-related sites. PTMExplorer currently supports eight model organisms, accepts user-uploaded differential analysis results, and provides multi-dimensional annotations and various visualization options (https://www.bioladder.cn/PTMExplorer/). Using a multi-omics dataset from hepatocellular carcinoma (18 patients, 9 modification types) as a case study, we demonstrate the practical utility of PTMExplorer in screening potential biomarkers, revealing multi-modification coordination mechanisms, and distinguishing between absolute and relative quantification patterns.

bioinformatics↗